Pharma companies in the metaverse? Maybe not yet, but time to start thinking future use, experts say
Thanks to Facebook’s name change to Meta last year, everyone is talking about the metaverse — especially companies and brands scrambling to figure out how they’re going to play on the platform. But should pharma companies be jumping in to the metaverse, whatever it is?
Yes and no, industry experts say. There are some initial plays for pharma, like using augmented or virtual reality to better show how a drug works or what Parkinson’s disease tremors feel like. The future of the metaverse is still very much in the future, along with its major uses across biopharma in R&D, patient communications, drug launches, manufacturing and marketing. But it is on the way.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 154,300+ biopharma pros reading Endpoints daily — and it's free.